4//SEC Filing
PRENDERGAST FRANKLYN G 4
Accession 0001213900-21-057327
CIK 0001763950other
Filed
Nov 7, 7:00 PM ET
Accepted
Nov 8, 4:05 PM ET
Size
5.3 KB
Accession
0001213900-21-057327
Insider Transaction Report
Form 4
PRENDERGAST FRANKLYN G
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-11-04+3,200→ 3,200 totalExercise: $10.32Exp: 2031-11-04→ Common Stock (3,200 underlying)
Footnotes (1)
- [F1]The Options are granted under the Lantern Pharma Inc. Amended and Restated 2018 Stock Incentive Plan. The Options shall vest and first become exercisable in equal monthly increments over a 36-month period commencing upon December 4, 2021.
Documents
Issuer
Lantern Pharma Inc.
CIK 0001763950
Entity typeother
Related Parties
1- filerCIK 0001233256
Filing Metadata
- Form type
- 4
- Filed
- Nov 7, 7:00 PM ET
- Accepted
- Nov 8, 4:05 PM ET
- Size
- 5.3 KB